LMLLF
Price:
$0.00855
Market Cap:
$1.07M
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in nor...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-05-19
Stock Exchange
PNK
Ticker
LMLLF
According to Pharmadrug Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -97.58% compared to the average of -2.06 of the last 4 quarters.
The mean historical PE Ratio of Pharmadrug Inc. over the last ten years is -10.07. The current -0.05 PE Ratio has changed -50.35% with respect to the historical average. Over the past ten years (40 quarters), LMLLF's PE Ratio was at its highest in in the September 2015 quarter at 57.52. The PE Ratio was at its lowest in in the September 2017 quarter at -125.91.
Average
-10.07
Median
-2.02
Minimum
-39.13
Maximum
-0.21
Discovering the peaks and valleys of Pharmadrug Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.24%
Maximum Annual PE Ratio = -0.21
Minimum Annual Increase = -96.34%
Minimum Annual PE Ratio = -39.13
Year | PE Ratio | Change |
---|---|---|
2023 | -0.21 | -87.54% |
2022 | -1.72 | -13.01% |
2021 | -1.97 | -4.52% |
2020 | -2.07 | 671.11% |
2019 | -0.27 | -95.67% |
2018 | -6.19 | -84.18% |
2017 | -39.13 | 3.24% |
2016 | -1.17 | -96.34% |
2015 | -32.08 | 101.83% |
2014 | -15.89 | 28.59% |
The current PE Ratio of Pharmadrug Inc. (LMLLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.30
5-year avg
-1.25
10-year avg
-10.07
Pharmadrug Inc.’s PE Ratio is less than Cannara Biotech Inc. (10.07), greater than CordovaCann Corp. (-0.80), less than Cannabis Strategic Ventures (0), greater than RAMM Pharma Corp. (-0.20), greater than Elixinol Wellness Limited (-5.45), less than CuraScientific Corp. (0.00), less than LiveWire Ergogenics, Inc. (1.62), less than Agra Ventures Ltd. (-0.01), less than Nunzia Pharmaceutical Company (0), less than CuraScientific Corp (0.00), less than Love Hemp Group Plc (-0.00), greater than Resonate Blends, Inc. (-0.09), greater than Revive Therapeutics Ltd. (-0.73), less than High Fusion Inc. (0), less than Green Cures & Botanical Distribution Inc. (1.81), greater than Nextleaf Solutions Ltd. (-15.21), greater than Blueberries Medical Corp. (-5.25), less than Sproutly Canada Inc. (-0.00), greater than MediPharm Labs Corp. (-2.07), greater than China SXT Pharmaceuticals, Inc. (-0.05),
Company | PE Ratio | Market cap |
---|---|---|
10.07 | $46.44M | |
-0.80 | $4.39M | |
0 | $18.76K | |
-0.20 | $15.16M | |
-5.45 | $1.10M | |
0.00 | $209.77K | |
1.62 | $831.19K | |
-0.01 | $341.86K | |
0 | $1.30M | |
0.00 | $37.73K | |
-0.00 | $11.99K | |
-0.09 | $451.80K | |
-0.73 | $2.51M | |
0 | $767.56K | |
1.81 | $783.95K | |
-15.21 | $8.65M | |
-5.25 | $3.79M | |
-0.00 | $50.70M | |
-2.07 | $17.00M | |
-0.05 | $1.21M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmadrug Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmadrug Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pharmadrug Inc.'s PE Ratio?
How is the PE Ratio calculated for Pharmadrug Inc. (LMLLF)?
What is the highest PE Ratio for Pharmadrug Inc. (LMLLF)?
What is the 3-year average PE Ratio for Pharmadrug Inc. (LMLLF)?
What is the 5-year average PE Ratio for Pharmadrug Inc. (LMLLF)?
How does the current PE Ratio for Pharmadrug Inc. (LMLLF) compare to its historical average?